Correlation Between VectivBio Holding and Inozyme Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VectivBio Holding and Inozyme Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VectivBio Holding and Inozyme Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VectivBio Holding AG and Inozyme Pharma, you can compare the effects of market volatilities on VectivBio Holding and Inozyme Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VectivBio Holding with a short position of Inozyme Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of VectivBio Holding and Inozyme Pharma.

Diversification Opportunities for VectivBio Holding and Inozyme Pharma

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between VectivBio and Inozyme is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding VectivBio Holding AG and Inozyme Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme Pharma and VectivBio Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VectivBio Holding AG are associated (or correlated) with Inozyme Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme Pharma has no effect on the direction of VectivBio Holding i.e., VectivBio Holding and Inozyme Pharma go up and down completely randomly.

Pair Corralation between VectivBio Holding and Inozyme Pharma

Given the investment horizon of 90 days VectivBio Holding AG is expected to generate 0.79 times more return on investment than Inozyme Pharma. However, VectivBio Holding AG is 1.27 times less risky than Inozyme Pharma. It trades about 0.14 of its potential returns per unit of risk. Inozyme Pharma is currently generating about 0.05 per unit of risk. If you would invest  822.00  in VectivBio Holding AG on August 23, 2024 and sell it today you would earn a total of  863.00  from holding VectivBio Holding AG or generate 104.99% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy30.44%
ValuesDaily Returns

VectivBio Holding AG  vs.  Inozyme Pharma

 Performance 
       Timeline  
VectivBio Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VectivBio Holding AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, VectivBio Holding is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Inozyme Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inozyme Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

VectivBio Holding and Inozyme Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VectivBio Holding and Inozyme Pharma

The main advantage of trading using opposite VectivBio Holding and Inozyme Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VectivBio Holding position performs unexpectedly, Inozyme Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme Pharma will offset losses from the drop in Inozyme Pharma's long position.
The idea behind VectivBio Holding AG and Inozyme Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Stocks Directory
Find actively traded stocks across global markets